| Dr Daniel Renfer, DO | |
|
650 Huebner Rd, Fort Riley, KS 66442-4030 | |
| (785) 239-7000 | |
| Not Available |
| Full Name | Dr Daniel Renfer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 650 Huebner Rd, Fort Riley, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508366105 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 2089 (Nebraska) | Primary |
| Entity Name | Sound Physicians Emergency Medicine Of Kansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831689934 PECOS PAC ID: 6800141672 Enrollment ID: O20180619001843 |
News Archive
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
Eight years ago, Lynette Kunz suffered a severe spinal cord injury that left her a quadriplegic and sufferer of involuntary bladder contractions.
Mylan Inc. today announced that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals related to Namenda® Tablets, 5 mg and 10 mg, known generically as Memantine Hydrochloride (HCl) Tablets.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Renfer, DO 650 Huebner Rd, Fort Riley, KS 66442-4030 Ph: () - | Dr Daniel Renfer, DO 650 Huebner Rd, Fort Riley, KS 66442-4030 Ph: (785) 239-7000 |
News Archive
New Phase II data, published today in the New England Journal of Medicine, showed that Eli Lilly and Company's ixekizumab, an anti-IL-17 monoclonal antibody, met its primary endpoint in patients with moderate-to-severe plaque psoriasis, with significantly more patients achieving at least a 75 percent improvement in Psoriasis Area and Severity Index (PASI) scores from baseline (PASI 75) compared with placebo at week 12.
Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that the European Commission, acting on the positive recommendation from the European Medicines Agency Committee for Orphan Medicinal Products (COMP), has granted orphan drug designation to synthetic hypericin (the active pharmaceutical ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma (CTCL), a rare disease and a class of non-Hodgkin's lymphoma, a type of cancer of the white blood cells that are an integral part of the immune system.
Eight years ago, Lynette Kunz suffered a severe spinal cord injury that left her a quadriplegic and sufferer of involuntary bladder contractions.
Mylan Inc. today announced that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals related to Namenda® Tablets, 5 mg and 10 mg, known generically as Memantine Hydrochloride (HCl) Tablets.
› Verified 6 days ago
Stephanie Allison Couch, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 814 Marshall Loop, Fort Riley, KS 66442 Phone: 785-240-1125 | |
Dr. Benjamin Salazar Yabut Jr., M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 316-321-3300 | |
Dr. Gerald Rex Stroud Jr., MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-8490 Fax: 630-570-5779 | |
Dr. Stuart Conner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-240-7777 | |
Dr. Samuel Docksey, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 706-721-7005 | |
Dr. Stephen Ingle, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 650 Huebner Rd, Fort Riley, KS 66442 Phone: 785-239-3627 |